Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 7, Issue 6 (2018)

Pharmacokinetic study of single dose intramuscular administration of enrofloxacin in barbari goats

Author(s):
J Talpade, K Shrman, RK Sharma, YP Sahni, RP Singh and S Soman
Abstract:
Enrofloxacin is a second generation fluoroquinolone, specially developed for therapeutic purpose in veterinary practice and extensively used in goats for therapeutic purposes. The present study was planned to study the pharmacokinetic of enrofloxacin after single dose intramuscular administration in 6 healthy Barbari goats. The study was conducted by following cross-over design. The enrofloxacin was injected @ 5mg/kg body weight through intramuscular route. After drug administration, blood sample were collected at different time intervals and the plasma concentration of enrofloxacin were measured by high performance liquid chromatography (HPLC) having PDA detector. The mean peak plasma drug concentration of 0.38±0.05 mg.ml-1 was achieved at 1h, however, effective therapeutic concentration (0.1mg.ml-1) was maintained up to 4h with mean concentration of 0.17±0.03 mg.ml-1 at 4 h. The mean absorption half-life of (t1/2ka) and elimination half-life (t1/2 b) were calculated to be 0.25±0.05h, and 2.07±0.31h, respectively. The mean apparent volume of distribution (Vdarea), volume of distribution at steady state (Vdss) and mean residential time (MRT) was calculated to be 10851.49±1353.06ml.kg-1, 12123.31±1196.69ml.kg-1 and 3.35±0.40h, respectively.
Pages: 609-611  |  446 Views  63 Downloads


The Pharma Innovation Journal
How to cite this article:
J Talpade, K Shrman, RK Sharma, YP Sahni, RP Singh, S Soman. Pharmacokinetic study of single dose intramuscular administration of enrofloxacin in barbari goats. Pharma Innovation 2018;7(6):609-611.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal


Call for book chapter